These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 10467384)

  • 41. Redefining functionality and treatment efficacy in multiple sclerosis.
    Foley JF; Brandes DW
    Neurology; 2009 Jun; 72(23 Suppl 5):S1-11. PubMed ID: 19506262
    [TBL] [Abstract][Full Text] [Related]  

  • 42. How are cognitive impairment, fatigue and signs of depression related to participation in daily life among persons with multiple sclerosis?
    Ben Ari Shevil E; Johansson S; Ytterberg C; Bergström J; von Koch L
    Disabil Rehabil; 2014; 36(23):2012-8. PubMed ID: 24524439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations.
    Rogers JM; Panegyres PK
    J Clin Neurosci; 2007 Oct; 14(10):919-27. PubMed ID: 17659875
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessing quality of life in people with multiple sclerosis.
    Nicholl CR; Lincoln NB; Francis VM; Stephan TF
    Disabil Rehabil; 2001 Sep; 23(14):597-603. PubMed ID: 11697457
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autonomic symptom burden is associated with MS-related fatigue and quality of life.
    Cortez MM; Nagi Reddy SK; Goodman B; Carter JL; Wingerchuk DM
    Mult Scler Relat Disord; 2015 May; 4(3):258-63. PubMed ID: 26008943
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quality of life in patients with multiple sclerosis.
    Kes VB; Cengić L; Cesarik M; Tomas AJ; Zavoreo I; Matovina LZ; Corić L; Drnasin S; Demarin V
    Acta Clin Croat; 2013 Mar; 52(1):107-11. PubMed ID: 23837280
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contribution of demographic, medical, and social support variables in predicting the mental health dimension of quality of life among people with multiple sclerosis.
    Schwartz C; Frohner R
    Health Soc Work; 2005 Aug; 30(3):203-12. PubMed ID: 16190296
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Energy-saving strategies in the treatment of fatigue in patients with multiple sclerosis. A pilot study].
    García-Burguillo MP; Aguila-Maturana AM
    Rev Neurol; 2009 Aug 16-31; 49(4):181-5. PubMed ID: 19621319
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patient reported outcomes in benign multiple sclerosis.
    Hviid LE; Healy BC; Rintell DJ; Chitnis T; Weiner HL; Glanz BI
    Mult Scler; 2011 Jul; 17(7):876-84. PubMed ID: 21372114
    [TBL] [Abstract][Full Text] [Related]  

  • 50. What drives quality of life in multiple sclerosis?
    Hemmett L; Holmes J; Barnes M; Russell N
    QJM; 2004 Oct; 97(10):671-6. PubMed ID: 15367738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Quality of life in multiple sclerosis. Measures, relevance, problems, and perspectives].
    Pöllmann W; Busch C; Voltz R
    Nervenarzt; 2005 Feb; 76(2):154-69. PubMed ID: 15702359
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relation of quantitative visual and neurologic outcomes to fatigue in multiple sclerosis.
    Chahin S; Miller D; Sakai RE; Wilson JA; Frohman T; Markowitz C; Jacobs D; Green A; Calabresi PA; Frohman EM; Galetta SL; Balcer LJ
    Mult Scler Relat Disord; 2015 Jul; 4(4):304-10. PubMed ID: 26195047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fatigue in multiple sclerosis is related to disability, depression and quality of life.
    Pittion-Vouyovitch S; Debouverie M; Guillemin F; Vandenberghe N; Anxionnat R; Vespignani H
    J Neurol Sci; 2006 Apr; 243(1-2):39-45. PubMed ID: 16434057
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quality of life in multiple sclerosis patients in Spain.
    Chang CH; Cella D; Fernández O; Luque G; de Castro P; de Andrés C; Casanova B; Hernández MA; Prieto JM; Fernández VE; de Ramón E;
    Mult Scler; 2002 Dec; 8(6):527-31. PubMed ID: 12474996
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic pain in multiple sclerosis: A 10-year longitudinal study.
    Young J; Amatya B; Galea MP; Khan F
    Scand J Pain; 2017 Jul; 16():198-203. PubMed ID: 28850402
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The impact of disabilities on quality of life in people with multiple sclerosis.
    Wynia K; Middel B; van Dijk JP; De Keyser JH; Reijneveld SA
    Mult Scler; 2008 Aug; 14(7):972-80. PubMed ID: 18632779
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is the concept of quality of life relevant for multiple sclerosis patients with cognitive impairment? Preliminary results of a cross-sectional study.
    Baumstarck K; Pelletier J; Aghababian V; Reuter F; Klemina I; Berbis J; Loundou A; Auquier P
    PLoS One; 2012; 7(1):e30627. PubMed ID: 22292002
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A health-related quality of life measure for multiple sclerosis.
    Vickrey BG; Hays RD; Harooni R; Myers LW; Ellison GW
    Qual Life Res; 1995 Jun; 4(3):187-206. PubMed ID: 7613530
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High concurrent presence of disability in multiple sclerosis. Associations with perceived health.
    Johansson S; Ytterberg C; Claesson IM; Lindberg J; Hillert J; Andersson M; Widén Holmqvist L; von Koch L
    J Neurol; 2007 Jun; 254(6):767-73. PubMed ID: 17401746
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A 10-year follow-up of a population-based study of people with multiple sclerosis in Stockholm, Sweden: changes in health-related quality of life and the value of different factors in predicting health-related quality of life.
    Chruzander C; Ytterberg C; Gottberg K; Einarsson U; Widén Holmqvist L; Johansson S
    J Neurol Sci; 2014 Apr; 339(1-2):57-63. PubMed ID: 24492009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.